213 results
424B5
AADI
Aadi Bioscience Inc
3 May 24
Prospectus supplement for primary offering
4:05pm
lung cancer (NSCLC) and other solid tumors. Under the terms of the agreement, Mirati will be responsible for sponsoring and operating the Phase 1/2 study
8-K
EX-10.1
uqn8e05h
2 Oct 23
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
8:30am
8-K
EX-10.4
9ld 8nypjim
2 Oct 23
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
8:30am
8-K
4o5sg06tnl8ygxhxonk
2 Oct 23
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
8:30am
8-K
EX-99.1
lsff5j3vjzt 05
2 Oct 23
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
8:30am